Inozyme Pharma (INZY) – Long Term Play with Q1 Catalysts (Thursday, Feb. 16, 2023 at 8 a.m. ET)

Research & Analysis BioPharma
7

I am fully out of all my positions: 135% on shares, 350% on Options. 5 wins, 1 fail so far for our biopharma thread which is fantastic :heart_hands:

5 Likes